Orexo

18,34 SEK

-4,97%

Mindre end 1K følgere

ORX

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Kvartalsdata

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Orexo

Q4/242024Q1/25Q2/25Q3/25Q4/252025Q1/26
Omsætning160,3590,0146,2118,2118,7-357,126,05,0
EBITDA28,923,45,9-10,1-9,8786,3772,3-66,1
EBIT-98,0-140,3-5,2-21,5-21,1-304,9-352,7-75,0
EBIT-%-61,1 %-23,8 %-3,6 %-18,2 %-17,8 %85,4 %-1.356,5 %-1.500,0 %
Overskud før skat-106,3-190,6-19,3-33,8-32,7-317,2-403,0-104,2
Netto indkomst-116,2-203,0-15,9-39,8-29,8724,8639,3-133,9